Dec
2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
Visit us
stand H2.C62
Zone

BrightGene Bio-Medical Technology Co.,Ltd

About Us

BrightGene Bio-medical Technology Co Ltd is a research driven biopharmaceutical company that engages in the R&D and manufacturing of innovative medicine as well as special generic APIs and FDFs with primary strategic focus on the regulated market. 

We have an exciting and very promising innovative pipeline including immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis.

In parallel, we have also developed a special generic pipeline of extremely challenging molecul...

  • Country/Region:
    China
  • On CPHI since:
    2015
Contact info
Event information
CPHI Middle East 2026
  • 14 Dec 2026 - 16 Dec 2026
  • Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
  • Visit us at stand H2.C62

Products Featured at CPHI Middle East 2026

  • MMAF

    Product MMAF

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • MMAE

    Product MMAE

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • Maytansinol

    Product Maytansinol

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-4

    Product DM-4

    • Status: Pre-validation • Usage:  Antibody-drug Conjugate
  • DM-1

    Product DM-1

    • Status: Validated • Usage:  Antibody-drug Conjugate